EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

COVID-19 IgG seropositivity and its determinants in occupational groups of varying infection risks in two Andean cities of Ecuador before mass vaccination

Jose E Leon-Rojas iD, Fernanda Arias-Erazo, Patricia Jiménez-Arias iD, Ricardo Recalde-Navarrete iD, Angel Guevara, Josefina Coloma, Miguel Martin, Irina Chis Ster iD, Philip Cooper, Natalia Romero-Sandoval, Seroprevalence ECU-Group

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0309466 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jose E Leon-Rojas und 10 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Pediatría, Obstetricia y Ginecología y Medicina Preventiva, Universitat Autonoma de Barcelona (UAB), Barcelona, Spain. Hauptthemen laut MEDLINE: Immunoglobulin G, COVID-19, SARS-CoV-2, Antibodies, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Internacional del Ecuador, Corporación Ecuatoriana para el Desarrollo de la Investigación y Academia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The COVID-19 pandemic has caused over 68.7 million infections and 1.35 million deaths in South America. There are limited data on SARS-CoV-2 seropositivity and its determinants from Andean countries prior to mass vaccinations against COVID-19.

Objective

To estimate SARS-CoV-2 seropositivity and its determinants before vaccination in occupational groups of adults presumed to have different levels of exposure and associations with potential symptomatology.

Methods

We measured seropositivity of anti-SARS-CoV-2 IgG antibodies in a cross-sectional study of vaccine-naïve adults aged 18 years and older, recruited within three occupational risk groups (defined as low [LR], moderate [MR], and high [HR]) between January and September 2021 in two Andean cities in Ecuador. Associations with risk factors were estimated using logistic regression.

Results

In a sample of 882 adults, IgG seropositivity for the three different occupational risk groups was 39.9% (CI 95% 35.3–44.6), 74.6% (CI 95% 66.4–81.4), and 39.0% (CI 95% 34.0–44.4) for the HR, MR, and LR groups, respectively. History of an illness with loss of taste and/or smell was significantly associated with seropositivity in all occupational groups, with adjusted ORs of 14.31 (95%CI, 5.83–35.12; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin GCOVID-19SARS-CoV-2Antibodies, ViralHumansEcuadorAdultMaleFemaleCross-Sectional StudiesMiddle AgedRisk FactorsMass VaccinationYoung AdultCOVID-19 VaccinesCitiesAdolescentOccupational Exposure

Substanzen

Immunoglobulin GAntibodies, ViralCOVID-19 Vaccines

Autor:innen und Institutionen

  • Departamento de Pediatría, Obstetricia y Ginecología y Medicina Preventiva, Universitat Autonoma de Barcelona (UAB), Barcelona, Spain.
  • Research Network Grups de Recerca d'Amèrica i Àfrica Llatines (GRAAL), Universidad Internacional del Ecuador, Quito, Ecuador.
  • School of Medicine, Universidad Internacional del Ecuador, Quito, Ecuador.
  • Grupo de Investigación en Sanidad Animal y Humana (GISAH) ESPE, Quito, Ecuador.
  • Departamento de Ciencias de la Vida y de la Agricultura, Universidad de las Fuerzas Armadas ESPE, Sangolquí, Ecuador.
  • Medical School, Universidad Tecnica de Ambato, Ambato, Ecuador.

ORCID-Profile: Jose E Leon-Rojas, Patricia Jiménez-Arias, Ricardo Recalde-Navarrete, Irina Chis Ster

Förderung

  • Universidad Internacional del Ecuador
  • Corporación Ecuatoriana para el Desarrollo de la Investigación y Academia

Zitieren

APA

Leon-Rojas, J. E., Arias-Erazo, F., Jiménez-Arias, P., Recalde-Navarrete, R., Guevara, A., Coloma, J., Martin, M., Chis Ster, I., Cooper, P., Romero-Sandoval, N., & Seroprevalence ECU-Group (2024). COVID-19 IgG seropositivity and its determinants in occupational groups of varying infection risks in two Andean cities of Ecuador before mass vaccination. PLOS ONE. https://doi.org/10.1371/journal.pone.0309466

Vancouver

Leon-Rojas JE, Arias-Erazo F, Jiménez-Arias P, Recalde-Navarrete R, Guevara A, Coloma J, et al. COVID-19 IgG seropositivity and its determinants in occupational groups of varying infection risks in two Andean cities of Ecuador before mass vaccination. PLOS ONE. 2024. doi:10.1371/journal.pone.0309466

BibTeX
@article{LeonRojas2024,
  author = {Leon-Rojas, Jose E and Arias-Erazo, Fernanda and Jiménez-Arias, Patricia and Recalde-Navarrete, Ricardo and Guevara, Angel and Coloma, Josefina and Martin, Miguel and Chis Ster, Irina and Cooper, Philip and Romero-Sandoval, Natalia and Seroprevalence ECU-Group, Seroprevalence ECU-Group},
  title = {COVID-19 IgG seropositivity and its determinants in occupational groups of varying infection risks in two Andean cities of Ecuador before mass vaccination},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0309466}
}
Kostenlos starten →